We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$214M
Cap. Flow
+$201M
Cap. Flow %
13.22%
Top 10 Hldgs %
33.88%
Holding
311
New
21
Increased
84
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$24.9M
2
SYK icon
Stryker
SYK
+$24.6M
3
APA icon
APA Corp
APA
+$23.1M
4
NUE icon
Nucor
NUE
+$21.9M
5
CMCSA icon
Comcast
CMCSA
+$18.9M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$32.8M
2
HBI
Hanesbrands
HBI
+$15.1M
3
CHD icon
Church & Dwight Co
CHD
+$9.02M
4
NEE icon
NextEra Energy
NEE
+$9M
5
KO icon
Coca-Cola
KO
+$5.35M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Materials 13.93%
3 Communication Services 13.6%
4 Healthcare 10.39%
5 Energy 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MT icon
276
ArcelorMittal
MT
$52.9B
$181K 0.01%
10,000
– –
BKD icon
277
Brookdale Senior Living
BKD
$3.49B
$175K 0.01%
10,000
– –
WLL
278
DELISTED
Whiting Petroleum Corporation
WLL
$175K 0.01%
67
– –
CVA
279
DELISTED
Covanta Holding Corporation
CVA
$154K 0.01%
10,000
– –
MNDT
280
DELISTED
Mandiant, Inc. Common Stock
MNDT
$147K 0.01%
10,000
– –
KN icon
281
Knowles
KN
$3.13B
$141K 0.01%
10,000
– –
BCS icon
282
Barclays
BCS
$92.7B
$135K 0.01%
16,499
-102
-0.6% -$805
PLUG icon
283
Plug Power
PLUG
$2.87B
$128K 0.01%
75,000
– –
TTNP
284
DELISTED
Titan Pharmaceuticals
TTNP
$118K 0.01%
6
– –
VUZI icon
285
Vuzix
VUZI
$194M
$97K 0.01%
+11,000
New +$88.5K
DDC
286
DELISTED
Dominion Diamond Corporation
DDC
$97K 0.01%
10,000
– –
CRDF icon
287
Cardiff Oncology
CRDF
$66.5M
$90K 0.01%
278
– –
CCJ icon
288
Cameco
CCJ
$37.6B
$86K 0.01%
10,000
– –
TNDM icon
289
Tandem Diabetes Care
TNDM
$1.34B
$81K 0.01%
1,063
– –
TNXP icon
290
Tonix Pharmaceuticals
TNXP
$160M
– –
0
– –
CHK
291
DELISTED
Chesapeake Energy Corporation
CHK
$72K ﹤0.01%
58
– –
TCRT icon
292
Alaunos Therapeutics
TCRT
$4.59M
$68K ﹤0.01%
80
– –
VVUS
293
DELISTED
Vivus Inc
VVUS
$11K ﹤0.01%
1,000
– –
SUNE
294
DELISTED
SUNEDISON, INC COM
SUNE
$1K ﹤0.01%
12,000
– –
APTV icon
295
Aptiv
APTV
$12B
– –
-3,500
Closed -$219K
AVAV icon
296
AeroVironment
AVAV
$7.56B
– –
-8,000
Closed -$222K
CWT icon
297
California Water Service
CWT
$3.1B
– –
-6,000
Closed -$210K
D icon
298
Dominion Energy
D
$60.8B
– –
-3,300
Closed -$257K
DD icon
299
DuPont de Nemours
DD
$18.5B
– –
-5,519
Closed -$695K
DHR icon
300
Danaher
DHR
$137B
– –
-2,976
Closed -$202K
9 10 11
12
13

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q3 2016 Portfolio in Review

As of Q3 2016, R.H. Bluestein & Co held 311 positions worth $1.52B, up 16% from $1.31B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

R.H. Bluestein & Co deployed $201M of net new capital in Q3 2016, opening 21 new positions and adding to 84 existing holdings. Its largest new stake was APA Corp: 423,532 shares worth $27.1M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Boston Scientific, an estimated $32.8M trimmed.

  • R.H. Bluestein & Co's largest Q3 2016 buy was APA Corp: 423,532 shares worth $27.1M.
  • R.H. Bluestein & Co added most to Chubb in Q3 2016, an estimated $24.9M increase.
  • R.H. Bluestein & Co's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $32.8M.
  • R.H. Bluestein & Co fully exited Hanesbrands in Q3 2016, selling an estimated $15.1M.
  • R.H. Bluestein & Co's ten largest holdings make up 34% of its $1.52B portfolio in Q3 2016.
  • R.H. Bluestein & Co opened 21 new positions and closed 15 in Q3 2016.
  • R.H. Bluestein & Co's portfolio value rose 16% quarter-over-quarter to $1.52B.

Based on R.H. Bluestein & Co's 13F filing for Q3 2016, filed 14 Nov 2016.